MSL
PCRX icon

Mackay Shields LLC’s Pacira BioSciences PCRX Stock Holding History

Mackay Shields LLC’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-62,085
Closed -$3.73M – 1570
2020
Q3 		$3.73M Sell
62,085
-11,900
-16% -$691K 0.03% 519
2020
Q2 		$3.88M Sell
73,985
-6,400
-8% -$267K 0.03% 488
2020
Q1 		$2.69M Sell
80,385
-6,800
-8% -$282K 0.02% 545
2019
Q4 		$3.95M Sell
87,185
-20,800
-19% -$883K 0.03% 561
2019
Q3 		$4.11M Buy
107,985
+10,100
+10% +$403K 0.03% 585
2019
Q2 		$4.26M Buy
97,885
+54,088
+123% +$2.3M 0.03% 592
2019
Q1 		$1.67M Buy
43,797
+7,200
+20% +$281K 0.01% 781
2018
Q4 		$1.57M Sell
36,597
-57,203
-61% -$2.67M 0.01% 751
2018
Q3 		$4.61M Sell
93,800
-24,700
-21% -$1.07M 0.04% 459
2018
Q2 		$3.8M Buy
118,500
+108,000
+1,029% +$3.73M 0.03% 560
2018
Q1 		$327K Buy
+10,500
New +$374K ﹤0.01% 1176

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return